Search research articles
Contact Us
Filters
Showing results (171-180 of 200) with videos related to
Page
of 20
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]
N Takifuji, M Fukuoka, S Negoro, et al.
Journal of Molecular and Cellular Cardiology
|
June 22, 2000
Isolation and characterization of the murine cardiotrophin-1 gene: expression and norepinephrine-induced transcriptional activation
M Funamoto, S Hishinuma, Y Fujio, et al.
European Journal of Pediatrics
|
June 1, 1989
Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient
S Doi, O Saiki, T Hara, et al.
No Shinkei Geka. Neurological Surgery
|
August 24, 2001
[Treatment for brain metastasis from lung cancer in the era of radiosurgery]
K Yamanaka, Y Iwai, H Nakajima, et al.
Diagnostic and Therapeutic Endoscopy
|
January 1, 1997
Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung Cancer
H Kato, T Okunaka, C Konaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 17, 2000
[Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group]
T Isobe, M Fukuoka, S Negoro, et al.
Breast Cancer Research and Treatment
|
September 10, 2014
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
M Tanioka, K Sakai, T Sudo, et al.
British Journal of Cancer
|
July 31, 1998
A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group
N Masuda, M Fukuoka, A Fujita, et al.
Circulation
|
September 15, 1996
Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction
K Iwakura, H Ito, S Takiuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)
I Sekine, Y Nishiwaki, K Noda, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 200) with videos related to
Sort By:
Page
of 20
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1990
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy]
N Takifuji, M Fukuoka, S Negoro, et al.
Journal of Molecular and Cellular Cardiology
|
June 22, 2000
Isolation and characterization of the murine cardiotrophin-1 gene: expression and norepinephrine-induced transcriptional activation
M Funamoto, S Hishinuma, Y Fujio, et al.
European Journal of Pediatrics
|
June 1, 1989
Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient
S Doi, O Saiki, T Hara, et al.
No Shinkei Geka. Neurological Surgery
|
August 24, 2001
[Treatment for brain metastasis from lung cancer in the era of radiosurgery]
K Yamanaka, Y Iwai, H Nakajima, et al.
Diagnostic and Therapeutic Endoscopy
|
January 1, 1997
Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung Cancer
H Kato, T Okunaka, C Konaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 17, 2000
[Pilot study of dose intensive weekly chemotherapy followed by cisplatin plus etoposide with concurrent thoracic irradiation for limited-disease small-cell lung cancer. West Japan Thoracic Oncology Group]
T Isobe, M Fukuoka, S Negoro, et al.
Breast Cancer Research and Treatment
|
September 10, 2014
Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
M Tanioka, K Sakai, T Sudo, et al.
British Journal of Cancer
|
July 31, 1998
A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group
N Masuda, M Fukuoka, A Fujita, et al.
Circulation
|
September 15, 1996
Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction
K Iwakura, H Ito, S Takiuchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2003
Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)
I Sekine, Y Nishiwaki, K Noda, et al.
Page
of 20